Transport characteristics of rutin deca (H-) sulfonate sodium across Caco-2 cell monolayers.
The aim of this study was to explore potential transport mechanisms of rutin deca (H-) sulfonate sodium (RDS) across Caco-2 cell monolayers. As an in-vitro model of human intestinal epithelial membrane, Caco-2 cells were utilized to evaluate the transepithelial transport characteristics of this hydrophilic macromolecular compound. Bi-directional transport study of RDS demonstrated that the apparent permeability (P(app)) in the secretory direction was 1.4 approximately 4.5-fold greater than the corresponding absorptive P(app) at concentrations in the range 50.0 approximately 2,000 microM. The transport of RDS was shown to be concentration, temperature and pH dependent. In the presence of ciclosporin and verapamil, potent inhibitors of P-glycoprotein (P-gp)/MRP2, the absorptive transport was enhanced and secretory efflux was diminished. RDS significantly reduced the efflux ratio of the P-gp substrate rhodamine-123 in a fashion indicative of P-gp activity suppression, while rhodamine-123 competitively inhibited the polarized transport of the compound. In conclusion, the results indicated that RDS was likely a substrate of P-gp. Several efflux transporters, including P-gp, participated in the absorption and efflux of RDS and they might play significant roles in limiting the oral absorption of the compound. These observations offered important information for the pharmacokinetics of RDS.
He
Ying
Y
Department of Pharmaceutical Analysis and Drug Metabolism, Zhejiang University, Hangzhou, P.R. China.
Zeng
Su
S
D001692:Biological Transport / Q000187:drug effects / Q000502:physiology; D018938:Caco-2 Cells; D002463:Cell Membrane Permeability / Q000187:drug effects* / Q000502:physiology; D016572:Cyclosporine / Q000494:pharmacology; D004347:Drug Interactions; D047309:Flavones / Q000378:metabolism / Q000493:pharmacokinetics; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008954:Models, Biological; D020112:Rhodamine 123 / Q000494:pharmacology; D012431:Rutin / Q000031:analogs & derivatives* / Q000378:metabolism / Q000493:pharmacokinetics*; D013696:Temperature; D014700:Verapamil / Q000494:pharmacology
D047309:Flavones; C509493:rutin decasulfonate sodium; D020112:Rhodamine 123; D012431:Rutin; D016572:Cyclosporine; D014700:Verapamil